Jiangsu Nhwa Pharmaceutical News

Jiangsu Nhwa Pharmaceutical: Announcement on obtaining the “Drug Registration Certificate”

May 24 00:00

Enhua Pharmaceutical: 002262 Enhua Pharmaceutical Investor Relations Management Information 20240425

Apr 25 16:45

Enhua Pharmaceutical: Announcement of Supervisory Board Resolutions

Apr 20 00:00

Enhua Pharmaceutical: Announcement of Board Resolutions

Apr 20 00:00

Enhua Pharmaceutical: 002262 Enhua Pharmaceutical Investor Relations Management Information 20240409

Apr 9 16:37

Enhua Pharmaceutical: Announcement on NH103 Obtaining the “Drug Clinical Trial Approval Notice”

Apr 3 00:00

Enhua Pharmaceutical: 2023 Annual Audit Report

Mar 30 00:00

Enhua Pharmaceutical: 2023 Independent Director Debriefing Report (Wang Guangji)

Mar 30 00:00

Enhua Pharmaceutical: 2023 Independent Director Debriefing Report (Li Yulan)

Mar 30 00:00

Enhua Pharmaceutical: Working System for Independent Directors (Revised Draft)

Mar 30 00:00

Enhua Pharmaceutical: Special explanation of the company's cumulative and current external guarantees by independent directors

Mar 30 00:00

Enhua Pharmaceutical: Announcement of Supervisory Board Resolutions

Mar 30 00:00

Enhua Pharmaceutical: Constitution of Jiangsu Enhua Pharmaceutical Co., Ltd. (March 28, 2024)

Mar 30 00:00

Enhua Pharmaceutical: Announcement of Board Resolutions

Mar 30 00:00

Enhua Pharmaceutical: Evaluation Report on the 2023 Performance Status of Accounting Firms

Mar 30 00:00

Enhua Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors

Mar 30 00:00

Enhua Pharmaceutical: Announcement on renewing the employment of an accounting firm

Mar 30 00:00

Enhua Pharmaceutical: Announcement on holding the 2023 Annual Results Briefing

Mar 30 00:00

Enhua Pharmaceutical: Independent Director's Prior Approval Opinion on Renewal of the Accounting Firm

Mar 30 00:00

Enhua Pharmaceutical: Independent Director\'s Annual Debriefing Report

Mar 30 00:00